Adenovirus type-5 vector-based Ebola vaccine was safe and immunogenic in healthy adults

Randomised, double-blind, placebo-controlled, phase 2 clinical trial at Sierra Leone
Randomised, double-blind, placebo-controlled, phase 2 clinical trial at Sierra Leone